Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Techne Gets New York State Approval for Prostate Cancer Test

NEW YORK (GenomeWeb) – Bio-Techne today announced that it has received a clinical laboratory permit from the New York State Department of Health to provide its liquid biopsy-based ExoDx Prostate IntelliScore (EPI) test in the state.

As a result, the test is available to patients in all 50 states in the US.

The EPI test assists physicians in determining the need for a prostate biopsy in patients with an ambiguous prostate specific antigen (PSA) test result. It tests for three exosomal RNA biomarkers to enable physicians to assess whether a patient presenting for an initial biopsy is at greater risk for high-grade prostate cancer.

Steve Silverman, vice president and general manager at Minneapolis-based Bio-Techne, said in a statement that obtaining the New York State license is an important achievement for the Exosome Diagnostics business unit, which the firm acquired in August 2018 for up to $575 million.

He said that the firm has "seen strong adoption by urologists across the country."

Since 2017, when Exosome Diagnostics launched the EPI test from its CLIA-accredited laboratory in Cambridge, Massachusetts, the lab has processed more than 25,000 tests, Bio-Techne said.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.